Q/C Technologies, Inc. (QCLS) Stock

Technology · Computer Hardware · Member of Other US Stocks

Q/C Technologies, Inc. (QCLS) closed at USD 0.54 on 2026-10-14, a change of -85.9 % over the past year, with a market capitalization of USD 4.57M.

Q/C Technologies, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Q/C Technologies, Inc. key figures

Previous close

USD 0.54 (2026-10-14)

1-year change

-85.9 %

Market cap

USD 4.57M

Enterprise value

USD -2.92M

P/E ratio (trailing)

0.21

P/E ratio (forward)

n/a

EPS (trailing)

2.68

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.29

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.07

Employees

3

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Q/C Technologies, Inc.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Q/C Technologies, Inc. and compare it with other stocks.